Login / Signup

An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide-induced cholestasis.

Ainoa UgarteLorena De la MoraMaría Martínez-RebollarJosep MallolasMontserrat Laguno
Published in: Antiviral therapy (2021)
Keyphrases
  • drug induced
  • high glucose
  • diabetic rats
  • antiretroviral therapy
  • emergency department
  • adverse drug